Biomarker Lens

Biomarkers · Chemical

Fragile X DNA Analysis, Fetus

Understand what Fragile X DNA Analysis, Fetus signals

LOINC codes
45327-4
Commercial laboratory assays
1

We have not added a physiological summary for this biomarker yet. Compare the commercial laboratory assays and population reference ranges below.

Compare commercial laboratory assays for Fragile X DNA Analysis, Fetus

Check orderable catalog codes, specimen types, fasting requirements, and demographic reference ranges across laboratories.

Fragile X DNA Analysis, Fetus

Laboratory
Quest Diagnostics
Test code
16300
Specimen
10 mL amniotic fluid collected in a sterile plastic leak-proof container
Fasting
Not stated
LOINC
45327-4
Turnaround
Set up: As needed (a.m.)

Laboratory assay overview

This test is to be used in the prenatal diagnosis of Fragile X (FX) syndrome in pregnancies where the mothers are identified carriers of gray zone (45-54), permutation (55-200), or full-mutation (>200) CGG repeat alleles. It can also be used in the prenatal diagnosis of fetuses whose siblings are affected with FX.

View complete laboratory reference notes

See Laboratory Report

Quest Diagnostics test directory, test code 16300

Verify these ranges and sources

We compile every detail above directly from named laboratory directories and published clinical studies. Laboratories calculate standard reference intervals from the statistical distribution of tested populations for a specific assay method and demographic group, rather than setting universal optimal targets.

Always review your personal lab results with a licensed clinician, or track your lab history and health goals in Aumnivida.

Spotted an error? Email hello@biomarkerlens.com with the page URL and the primary source that corrects the entry.